Transfusion Medicine

Papers
(The median citation count of Transfusion Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU‐216
Understanding hepcidin for iron management in pregnancy16
The impact of pathogen‐reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trial15
The influence of the COVID‐19 pandemic on blood donation and supply in China14
Congress report: Online workshop on assessment of technical files for blood screening in vitro diagnostics for sub‐Sahara African countries12
10
Issue Information9
Re‐examine the transfusion transmitted risk of SARS‐CoV‐2 virus during a major COVID‐19 outbreak in 20229
2021: That was the year that was9
High B‐cell activating factor levels in multi‐transfused thalassemia patients9
9
On consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities9
Platelets inhibit erythrocyte invasion by Plasmodium falciparum at physiological platelet:erythrocyte ratios8
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre8
Fresh frozen plasma: Beyond coagulation factor content8
Validation of the Sysmex XN analyser and Blood Bank mode for the quality and safety of donor blood and transfusion products8
Author Index7
Chikungunya virus seroprevalence in asymptomatic blood donors during an outbreak in the Federal District of Brazil7
Evidence cornered: Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT trial)7
Issue Information7
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major7
Issue Information7
Suggested blood donor deferral strategy regarding hepatitis B infections in China6
BGvar: A comprehensive resource for blood group immunogenetics6
Surgical patients' perception about risks related to blood transfusion: A cross‐sectional survey5
5
Stability of immunohaematological reagents used for blood typing of recipients in the tube technique5
Evidence Cornered: Transfusion Evidence Summary – Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial)5
An accurate genetic assay to identify human neutrophil antigen 2 deficiency5
Iron deficiency in whole blood donors in a resource‐poor setting: A cross‐sectional study in Uganda5
Improvement of platelet preservation by inhibition ofTRPC65
Evidence cornered: Transfusion evidence summary—efficacy and safety of early administration of 4‐factor prothrombin complex concentrate in patients with trauma at risk of massive transfusio5
Frequency of red blood cell phenotypes from genotyped Australian blood donors5
Issue Information5
Low‐titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experience5
Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia4
Role of disruptions in O RhD negative donations in Colombia on increasing maternal mortality ratio from haemorrhage4
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study4
Drivers of blood use in paediatric trauma: A retrospective cohort study4
HLA‐DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization4
4
Plenary I4
Author Index4
Recovery of platelet‐rich red blood cells and acquisition of convalescent plasma with a novel gravity‐driven blood separation device3
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity3
Implementation challenges of electronic blood transfusion safety systems: Lessons from an international, multi‐site comparative case study3
The infected blood inquiry: Impact on public perceptions of blood supply risk, safety, and donation attitudes3
Charles Waller and Edward Doubleday—Colleagues of James Blundell and early supporters of blood transfusion3
Frequencies of different blood group antigens and phenotypes in Northern Vietnamese donors3
Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation3
Transfusion sample mislabelling and wrong blood in tube in the UK: Insights from the national comparative audits of blood transfusion in 2012 and 20223
Individual and environmental determinants of serum ferritin levels: A structural equation model3
Validation of pathogen reduced plasmas from maxi‐pools combined with fast thawing3
Using trends and outliers in managing delayed transfusions3
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada3
Red blood cell inventory management: Insights from transfusion laboratory technologists in British Columbia, Canada3
An evaluation of diethylhexyl phthalate free top & bottom in‐line blood collection set with a new soft housing filter3
Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP3
A review of immunoglobulin use in a district general hospital setting3
Blood transfusion demands in a tertiary otolaryngology, head and neck centre: A 5‐year retrospective cohort study3
Comparison of European recommendations about patient blood management in postpartum haemorrhage2
Sickle cell disease patients in two London trusts: Genotyping including RH variants2
Corrigendum2
Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–20152
Wednesday 11 October 2023 Simultaneous Sessions2
Reflection from managing blood supply during social unrest2
Resuscitation of adult shocked trauma patients using major haemorrhage protocol guided by viscoelastic haemostatic assays versus formulaic approach2
Perioperative transfusion study (PETS): Does a liberal transfusion protocol improve outcome in high‐risk cardiovascular patients undergoing non‐cardiac surgery? A randomised controlled pilo2
2
Reactions to serum eye drops—New Zealand experience and review of the literature2
Assessment the knowledge of blood transfusion in Iranian nurses of Tehran's hospitals2
Wednesday 18 September 2024 Simultaneous sessions2
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection2
Confirmed non‐invasive prenatal testing for foetal Rh blood group genotyping along with bi‐allelic short insertion/deletion polymorphisms as a positive internal control2
Assessing motivations for non‐living and living organ donation among individuals with and without a history of blood donation2
Risk of transfusion‐associated malaria in sub‐Saharan Africa: The case of Mali2
Identification of a novel RHCE*Ce (829G > A) allele associated with absence of C and e antigens expression2
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach2
An 8‐year retrospective review of human albumin solution use August 2015 to March 2023; Guy's and St Thomas' NHS Foundation Trust2
Factors influencing white blood cell mobilisation in healthy granulocyte donors2
Issue Information2
Utility of pre‐operative haemoglobin concentration to guide peri‐operative blood tests for hip and knee arthroplasty: A decision curve analysis2
Molecular validation of pathogen‐reduction technologies using rolling‐circle amplification coupled with real‐time PCR for torquetenovirus DNA quantification2
The ongoing dilemma of prophylactic platelet transfusions pre‐procedure and the development of evidence‐based recommendations2
2
Plenary session I2
Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting1
Corrigendum1
Acute haemolytic transfusion reaction after transfusion of fresh frozen plasma in a neonate—Preventable by using solvent/detergent‐treated pooled plasma?1
Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion1
Blood transfusion in the Caribbean: Historical perspective in the context of Trinidad and Tobago1
Preventing antibody positive delayed hemolytic transfusion reactions in sickle cell disease: Lessons learned from a case1
Bone marrow changes in a fatal case of transfusion associated—Graft versus host disease1
Reflections of a re‐engaged donor. A response to ‘on consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities’1
Evaluation of platelet concentrates prepared using different methods after overnight holding (18–24 h) of whole blood at room temperature1
Issue Information1
Prevalence and incidence of transfusion‐transmissible infections among blood donors in Malawi: A population‐level study1
Safe handovers: Safe patients‐why good quality structured handovers in the transfusion laboratory are important1
Issue Information1
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation1
A multidisciplinary comparison of transfusion and perioperative support for high‐risk cardiac surgery at three large academic centres in North America1
Issue Information1
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors1
Use of automated haematology analysers for the quality control of blood components for transfusion: Comment on Valina et al. (Transfusion Medicine 2024;34:30–38)1
Evaluation of two temperature storage conditions for full blood count samples from Lifeblood's donors1
Plenary session III1
Issue Information1
1
COP27 Climate Change Conference: Urgent action needed for Africa and the world1
Poster session1
Machine learning for predicting preoperative red blood cell demand1
Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo1
The importance of need‐altruism and kin‐altruism to blood donor behaviour for black and white people1
Patterns of paediatric massive blood transfusion protocol use in trauma and non‐trauma patients1
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis1
‘Old is gold’ does conventional test tube method still reign supreme? An immuno‐haematological survey of anti‐D detection and titration in ante‐natal cases among major hospitals across India1
Prevalence, incidence, risk factors and residual risk associated with viral infections among eligible Brazilian blood donors1
Issue Information1
The feasibility of introducing a whole blood component for traumatic haemorrhage in the UK1
Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China1
Reviewer Acknowledgement 20211
Plasma exchange in acute hemolytic reaction due to ABO‐incompatible erythrocyte concentrate transfusions: Single center experience1
The need for and challenges of comparing SARS‐CoV‐2 antibody assays1
Optimizing blood utilization: Experience of blood redistribution policy from a tertiary care hospital based blood centre1
The lack of anti‐PF4 antibodies in convalescent plasma from COVID‐19 infected blood donor1
Wednesday 14 September 2022 Simultaneous Session1
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene1
Hemolysis during therapeutic plasma exchange: A rare phenomena1
Preliminary study on the function of TMEM50A and its correlation with the RH genes1
Notes from the Basho of the blood service1
Transfusing selected RhD negative patients with RhD positive packed red cell concentrates resulted in lower frequency of anti‐D development and saved almost two thousand RhD1
Anti‐AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia1
Validation of current commercially‐available devices to thaw pooled, solvent/detergent‐treated human plasma1
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England1
BNT162b2 mRNA vaccine in transfusion dependent thalassemia patients1
Every minute counts: A comparison of thawing times and haemostatic quality of plasma thawed at 37°C and 45°C using four different methods1
1
Amber coloured plasma—Case for illustration1
Issue Information1
Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab1
D‐‐phenotype due to RHD‐RHCE hybrid transcript in a case of severe haemolytic disease of newborn with anti‐Rh 17(Hrₒ) antibodies1
Discrepancies among studies reporting the prevalence of positive direct antiglobulin tests in the COVID‐19 patient population1
1
Issue Information1
1
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors1
Universal new blood cell elution method with extensive phenotyping1
Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis1
Lipidomic changes occurring in platelets during extended cold storage1
Cold agglutinin syndrome in a patient with anaemia and beta‐thalassemia trait1
Survey of iron prescribing practices for post‐partum anaemia1
Blood transfusion in injured older adults: A retrospective cohort study0
Introduction of EUBIS standards to upgrade inspections of blood establishments to improve the safety of blood transfusion: The Polish experience0
Tuesday 10 October 2023 Sig Session0
Utility of rotational thromboelastometry in the management of massive haemorrhage at a regional Australian hospital0
Issue Information0
Does decreasing the incubation period used in the antibody screen affect its sensitivity?0
Construction of a decision model for donor testing in cases of suspected antibody‐mediated transfusion‐related‐acute‐lung‐injury0
Preventing misinterpretation of rare blood types in clinical laboratories: A case study on B3 phenotype0
Chikungunya and Mayaro infective viruses in components of blood0
Kinetics of anti‐SARS‐COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability0
Effects of storage on quality and function of acid‐treated platelets with reduced HLA Class I surface expression0
0
Establishment and discussion of autoverification rules for transfusion compatibility testing0
Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study0
Comparing transfusion practice at multiple hospitals using electronically collected and analysed data0
Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID‐19): Evidence‐0
Issue Information0
Author Index0
Extracellular vesicles in ageing cold‐stored whole blood may not compensate for the decreasing haemostatic function in vitro0
Acute pancreatitis from a delayed haemolytic transfusion reaction0
Impact of the COVID‐19 outbreak on blood supply in two large university hospitals0
Poster session: Blood donation (including donor safety)0
A novel homozygous splice‐site mutation of JK gene leads to Jk(a‐b‐) phenotype0
E‐learning/online education in transfusion medicine: A cross‐sectional international survey0
Tuesday 17 September 2024 SIG session0
Issue Information0
Recurrent pregnancy loss in a patient with anti‐Rh170
Prophylactic tranexamic acid use in non‐cardiac surgeries at high risk for transfusion0
UK national survey of anticoagulation in extra‐corporeal photopheresis—Is it time for a UK consensus statement?0
Issue Information0
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England0
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia0
Risk factors for red blood cell alloimmunization in patients with hematologic malignancy0
Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light0
Histo‐blood group A is a risk factor for severe COVID‐190
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review0
Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections0
Poster Presentations0
Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso0
Rare Pk phenotype caused by a novel frameshift mutation in B3GALNT10
Analysis of a 5‐year, evidenced‐based, rational blood utilisation project in a South African regional hospital0
Genetic variation of FUT3 gene in the Han population from Northern China0
Beyond COVID‐19 and lessons learned in the United States0
Development and validation of an indigenous questionnaire for assessing clinician's knowledge towards transfusion medicine and bedside transfusion practices0
Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients0
An unusual case of reagent interference in transfusion medicine workup: Pan reactive indirect antiglobulin test caused by commercial saline solution0
Red blood cell transfusion in myelodysplastic syndromes: A systematic review0
Plenary III0
Rh(D) immune globulin administration in pregnancy: Retrospective audit of patient safety events followed by targeted educational intervention with Bayesian analysis0
Designing and testing an ethnic‐ancestry question for Australian blood donors: Acceptability, feasibility, and understanding0
Issue Information0
0
0
Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa0
0
Passenger lymphocyte syndrome with severe haemolysis misdiagnosed/treated as cold agglutinin syndrome: Analysis of case and diagnostic error0
Issue Information0
0
0
Transfusion Camp: The UK experience and its value in improving knowledge of transfusion medicine among postgraduate trainees0
Comparison of conventional coagulation tests and ROTEM in identifying trauma‐induced coagulopathy for massive haemorrhage protocol activation0
HLA class I and HPA9b related fetal‐neonatal alloimmune thrombocytopenia0
Trust and distrust: Identifying recruitment targets for ethnic minority blood donors0
Role of ABO blood system in COVID‐19: Findings from a southern Italian study0
How do we translate gaps and unmet needs of blood management for thalassemia into a collaborative implementation framework?0
Evaluating utility of routine ferritin testing in blood donors: A hospital‐based blood donor centre experience0
Convalescent plasma and COVID‐19: Time for a second—second look?0
Poster Presentations0
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective0
Early alloimmunization in an infant to red cell antigens—Rare but possible in the ‘right’ circumstances0
Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation0
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis0
Blood transfusion needs in COVID‐19 patients: An observational prospective unicentric study0
A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza0
Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako0
Investigating non‐immune haemolytic transfusion reactions in surgical patients0
A prospective, multi‐centric study on the prevalence of dengue, zika and chikungunya in asymptomatic blood donors from different geographical regions of Brazil0
Association between the length of storage of transfused leukoreduced red blood cell units and hospital‐acquired infections in critically ill children: A secondary analysis of the TRIPICU st0
Issue Information0
A challenge for blood management: A patient presenting anti‐Vel antibody undergoing orthotopic liver transplantation0
Probable cefepime‐induced immune mediated hemolytic anaemia0
An assessment of the management of anaemia in acute care settings in the United Kingdom: The value of a collaborative approach0
Issue Information0
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood0
Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony‐stimulating factor for severe hypoxemia provoked by high‐dose granulocyte colony‐0
0
Prevention strategies for vasovagal reaction in whole blood donors: A quadri‐armed randomised control trial0
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature0
Characterising practice patterns of human derived, lyophilized coagulation concentrates within the trauma quality improvement program registry0
A second look at the mortality in thrombotic thrombocytopenic purpura score: An external validation study0
0
Allogenic and autologous nondiluted serum eye drops—validation strategy compliant with good manufacturing practice0
0
The use of predictive modelling to determine the likelihood of donor return during the COVID‐19 pandemic0
Therapeutic apheresis and non‐blood donor related apheresis current practices at various blood centres of healthcare organisations of India: A brief online survey0
Hyperhaemolysis caused by anti‐HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion0
0
The contribution and potential of older blood donors in Asia Pacific regions0
Sample collection for pre‐transfusion crossmatching: Benefits of using an electronic identification system0
0.034533023834229